🇺🇸 FDA
Patent

US 9597357

T cell modifying compounds and uses thereof

granted A61KA61K35/26A61K40/11

Quick answer

US patent 9597357 (T cell modifying compounds and uses thereof) held by Sangamo Biosciences, Inc. expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K35/26, A61K40/11, A61K40/31, A61K40/4205